Thank you for visiting the website for Unity Biotechnology (“Company”), a biotechnology company formerly based in San Francisco, CA. The Company is no longer operating.

Unity BioTechnologies, a company backed by Jeff Bezos and PayPal co-founder Peter Thiel, [6] was co-founded in March 2009 by Nathaniel David, Jan Van Deursen, Judith Campisi, and …

Jun 30, 2025 · Unity Biotechnology (UBX, Financials) shares collapsed nearly 49% Monday after the company disclosed that Nasdaq plans to delist its stock, citing diminished operations and …

Oct 1, 2025 · Get the latest Unity Biotechnology, Inc. (UNBX) stock price with financials, statistics, dividends, charts and more.

May 5, 2025 · Longevity focused biotech company UNITY Biotechnology has released complete 36-week data from its Phase 2b ASPIRE clinical study, along with a corporate update …

Jun 30, 2025 · Unity Biotechnology (UBX), a company previously focused on developing therapies for age-related diseases, is set to be delisted from the Nasdaq Global Select Market and …

Mar 24, 2025 · UNITY is developing a new class of therapeutics to slow, halt, or reverse diseases of aging. UNITY’s current focus is on creating medicines to selectively eliminate or modulate …

Company Overview UNITY Biotechnology is developing transformative medicines by leveraging fundamental pathways of aging biology, with a focus in retinal diseases.

Discover real-time Unity Biotechnology Inc. (UBX) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions. Stay ahead with Nasdaq.

SAN FRANCISCO, March 07, 2025 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt, or …